tiprankstipranks
Delorean Corporation Ltd (AU:DEL)
ASX:DEL
Australian Market
Want to see AU:DEL full AI Analyst Report?

Delorean Corporation Ltd (DEL) AI Stock Analysis

19 Followers

Top Page

AU:DEL

Delorean Corporation Ltd

(Sydney:DEL)

Select Model
Select Model
Select Model
Neutral 44 (OpenAI - 5.2)
Rating:44Neutral
Price Target:
AU$0.09
â–¼(-20.00% Downside)
Action:ReiteratedDate:05/01/26
The score is primarily weighed down by weak financial performance (sharp revenue decline, persistent losses, high leverage, and negative operating/free cash flow). Technical indicators are mixed with slight oversold signals but the price remains below major moving averages, offering limited offset. Valuation is also pressured by loss-making results (negative P/E) and no dividend yield support.
Positive Factors
Specialized bioenergy business model
Delorean’s core business—capturing methane-rich biogas and converting it to energy—is a durable, project-driven model with multiple monetisation paths (energy sales, environmental attributes, and services). This vertical focus supports recurring cash flows from operating assets and aligns with long-term demand for low‑emission energy solutions.
Negative Factors
Sharp revenue decline
A near‑41% revenue decline undermines scale economics and signals weakening commercial performance or slower project commissioning. Over several quarters this erodes margin absorption, reduces cash available for reinvestment, and makes it harder to achieve sustainable growth or attract favourable project financing.
Read all positive and negative factors
Positive Factors
Negative Factors
Specialized bioenergy business model
Delorean’s core business—capturing methane-rich biogas and converting it to energy—is a durable, project-driven model with multiple monetisation paths (energy sales, environmental attributes, and services). This vertical focus supports recurring cash flows from operating assets and aligns with long-term demand for low‑emission energy solutions.
Read all positive factors

Delorean Corporation Ltd (DEL) vs. iShares MSCI Australia ETF (EWA)

Delorean Corporation Ltd Business Overview & Revenue Model

Company Description
Delorean Corporation Limited engages in the renewable energy and waste management businesses in Australia and New Zealand. It operates through four segments: Infrastructure, Engineering, Energy Retail, and Corporate. The company manufactures and f...
How the Company Makes Money
DEL makes money primarily through (1) energy and gas-related revenues from bioenergy assets and (2) fees and margins from providing engineering/project delivery services. Where DEL owns or co-owns operating bioenergy plants, it generates recurring...

Delorean Corporation Ltd Financial Statement Overview

Summary
Weak fundamentals: revenue declined sharply (-40.99%), profitability is deeply negative (net margin -33.02%, EBIT margin -32.10%, negative gross margin), leverage is high (debt-to-equity 3.99) with very poor shareholder returns (ROE -83.44%), and operating/free cash flow are negative—raising sustainability risk despite a positive free-cash-flow-to-net-income ratio (3.80).
Income Statement
25
Negative
Balance Sheet
30
Negative
Cash Flow
35
Negative
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue14.23M19.83M27.88M19.25M39.33M27.88M
Gross Profit-5.73M-2.99M7.83M-7.18M-6.77M-342.89K
EBITDA-7.89M-6.13M5.04M-9.06M-11.87M-4.08M
Net Income-8.99M-6.55M4.77M-10.02M-10.89M-3.21M
Balance Sheet
Total Assets50.62M48.30M28.05M17.92M24.10M28.77M
Cash, Cash Equivalents and Short-Term Investments4.85M10.66M8.84M1.00M3.12M13.07M
Total Debt38.45M31.31M9.07M7.62M2.63M2.78M
Total Liabilities46.75M40.45M19.28M15.75M12.21M12.50M
Stockholders Equity3.88M7.85M8.77M2.17M11.88M16.27M
Cash Flow
Free Cash Flow-26.62M-21.50M6.89M-6.80M-15.21M-2.59M
Operating Cash Flow-3.24M-5.66M7.24M-5.36M-11.77M156.59K
Investing Cash Flow-21.51M-15.08M-3.92M-1.44M-3.44M-4.49M
Financing Cash Flow16.22M23.33M915.22K4.68M5.26M14.49M

Delorean Corporation Ltd Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.11
Price Trends
50DMA
0.10
Positive
100DMA
0.11
Negative
200DMA
0.13
Negative
Market Momentum
MACD
<0.01
Negative
RSI
53.09
Neutral
STOCH
24.03
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:DEL, the sentiment is Positive. The current price of 0.11 is above the 20-day moving average (MA) of 0.10, above the 50-day MA of 0.10, and below the 200-day MA of 0.13, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 53.09 is Neutral, neither overbought nor oversold. The STOCH value of 24.03 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:DEL.

Delorean Corporation Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (66)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
66
Neutral
$17.65B18.105.60%3.62%6.62%11.55%
44
Neutral
AU$21.78M-4.53-153.29%―-58.56%-313.17%
44
Neutral
AU$24.46M-3.24-13.64%―16.99%―
―AU$24.78M0.09-31.05%―――
60
Neutral
AU$24.55M4.986.92%―-8.32%-67.69%
58
Neutral
AU$18.26M3.47-45.61%―-2.45%-211.48%
48
Neutral
AU$21.41M-0.61-108.64%――-63.48%
* Utilities Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:DEL
Delorean Corporation Ltd
0.09
-0.07
-44.38%
AU:CCE
Carnegie Clean Energy Ltd
0.06
0.02
53.85%
AU:JNS
ReNu Energy Limited
0.21
<0.01
5.00%
AU:LPE
Locality Planning Energy Holdings Limited
0.10
-0.03
-23.08%
AU:14D
1414 Degrees Ltd.
0.04
0.02
133.33%
AU:VPR
Volt Power Group Ltd
0.15
0.03
30.43%

Delorean Corporation Ltd Corporate Events

Delorean opens bioenergy project and management to investors with site tour and WA event
May 6, 2026
Delorean Corporation has announced two investor-focused events aimed at showcasing its build-own-operate bioenergy strategy and growing asset portfolio. The initiatives are designed to deepen engagement with shareholders and potential investors by...
Delorean sets May investor webinar to outline strategy and share plan
May 5, 2026
Delorean Corporation Limited, a leading Australian bioenergy specialist in renewable energy and waste management, operates an integrated model spanning engineering, infrastructure and energy retail to deliver bioenergy projects from conception to ...
Delorean launches shareholder offer to fund bioenergy growth push
May 4, 2026
Delorean Corporation has opened a share purchase plan for eligible shareholders, following a $2.2 million strategic placement to biogas specialist LMS Energy at $0.09 per share. The offer allows existing investors to acquire shares on the same ter...
Delorean launches compliant share purchase plan for eligible investors
May 3, 2026
Delorean Corporation Ltd has announced a share purchase plan offering eligible shareholders the opportunity to acquire up to $30,000 of new ordinary shares. The offer will be made without a full prospectus under ASIC Corporations Instrument 2019/5...
Delorean Raises Capital With 24.4 Million-Share Placement
Apr 30, 2026
Delorean Corporation has issued 24.4 million fully paid ordinary shares at $0.09 each via a placement to investors, expanding its capital base without providing a traditional disclosure document. The company states it is fully compliant with its f...
Delorean Options Lapse, Trimming Potential Future Dilution
Apr 30, 2026
Delorean Corporation has reported the cessation of 2,500,000 DELAH options, which were scheduled to expire on 30 November 2028 with an exercise price of $0.25. The options lapsed unexercised on 1 May 2026, resulting in a reduction of potential dil...
Delorean Options Lapse, Simplifying Capital Structure
Apr 30, 2026
Delorean Corporation Ltd has announced the cessation of 2,500,000 DELAG options, which were scheduled to expire on 30 November 2028 with an exercise price of $0.19. The options lapsed on 1 May 2026 without being exercised or converted, resulting i...
Delorean launches securities purchase plan to issue up to 73.4m shares
Apr 30, 2026
Delorean Corporation Limited has announced a securities purchase plan for its shareholders, offering up to 73,403,446 new ordinary fully paid shares. The offer is based on a record date of 29 April 2026 and is scheduled to close on 25 May 2026, wi...
Delorean secures $2.2m strategic biogas partner and launches $2.2m SPP
Apr 30, 2026
Delorean Corporation has secured a $2.2 million strategic investment from LMS Energy through a placement of 24.4 million shares at $0.09, giving LMS a 9.97% stake and bringing in a sector specialist that already operates more than 70 biogas projec...
Delorean advances Australian bioenergy pipeline with key project milestones and funding
Apr 30, 2026
Delorean reported a cash balance of $7.2 million at 31 March 2026 and customer receipts of $0.8 million for the quarter, highlighting continued investment in its bioenergy portfolio. The company is benefiting from strong policy momentum for renewa...
Delorean Seeks Two-Day Trading Halt Ahead of Capital Raising
Apr 29, 2026
Delorean Corporation has requested an immediate two-day trading halt on its ordinary shares on the ASX, effective from the market open on Wednesday, 29 April 2026. The halt is scheduled to last until either the company releases a further announcem...
Delorean Reaches Final Investment Decision on $62m NSW Bioenergy Plant
Apr 7, 2026
Delorean Corporation has approved a $62.1 million final investment decision for its 100%-owned NSW1 Horsley Park bioenergy facility in New South Wales, subject to securing $31.6 million in additional funding. The plant, co-located on Brickworks&#8...
Delorean secures further ARENA funding as SA1 Salisbury bioenergy plant advances
Mar 5, 2026
Delorean Corporation has received a $1.1 million second milestone payment under a $6.08 million Australian Renewable Energy Agency grant, bringing total grant funding received to $3.8 million for its SA1 Salisbury bioenergy facility in South Austr...
Delorean Warns Investors Over Limits of Bioenergy Sector Update
Feb 26, 2026
Delorean Corporation has issued an investor update dated late February 2026 outlining general information about its business and operations in the bioenergy sector. The document emphasises that the material is a high-level overview and may change ...
Delorean Highlights Bioenergy Growth in Interim 2025 Update
Feb 26, 2026
Delorean Corporation has released its interim financial report for the half-year ended 31 December 2025, outlining its progress toward becoming a leading renewable energy generator and retailer in Australia and New Zealand. The update highlights i...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 01, 2026